Author:
Zhang Ludi,Shao Yanjiao,Li Lu,Tian Feng,Cen Jin,Chen Xiaotao,Hu Dan,Zhou Yan,Xie Weifen,Zheng Yunwen,Ji Yuan,Liu Mingyao,Li Dali,Hui Lijian
Publisher
Springer Science and Business Media LLC
Reference56 articles.
1. Lindblad, B., Lindstedt, S. & Steen, G. On the enzymic defects in hereditary tyrosinemia. Proceedings of the National Academy of Sciences of the United States of America 74, 4641–4645 (1977).
2. Kvittingen, E. A. Hereditary tyrosinemia type I–an overview. Scandinavian journal of clinical and laboratory investigation. Supplementum 184, 27–34 (1986).
3. Tanguay, R. M. et al. Different molecular basis for fumarylacetoacetate hydrolase deficiency in the two clinical forms of hereditary tyrosinemia (type I). American journal of human genetics 47, 308–316 (1990).
4. St-Louis, M. & Tanguay, R. M. Mutations in the fumarylacetoacetate hydrolase gene causing hereditary tyrosinemia type I: overview. Human mutation 9, 291–299, 10.1002/(SICI)1098-1004(1997)9:4<291::AID-HUMU1>3.0.CO;2-9 (1997).
5. Scriver, C. R. The metabolic & molecular bases of inherited disease. Vol. 4 (New York; Montreal: McGraw-Hill, 2001).
Cited by
58 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献